secwatch / observer
8-K filed May 16, 2024, 7:59 PM ET ticker GPI CIK 0001031203
other confidence high sentiment neutral materiality 0.40

Group 1 stockholders approve 2024 ESPP and 2024 Long-Term Incentive Plan at annual meeting

GROUP 1 AUTOMOTIVE INC

item 5.02item 5.07item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001031203-24-000040
form_type
8-K
ticker
GPI
cik
0001031203
company_name
GROUP 1 AUTOMOTIVE INC
filed_at
2024-05-16T23:59:59+00:00
discovered_at
2026-05-14T18:03:16.944479+00:00
generated_at
2026-06-01T18:30:52.527470+00:00
sec_items
["5.02", "5.07", "9.01"]
event_type
other
sentiment
neutral
materiality_score
0.4
calibrated_materiality_score
0.4
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001031203-24-000040
json_url
https://secwatch.observer/filing/0001031203-24-000040.json
markdown_url
https://secwatch.observer/filing/0001031203-24-000040.md
text_url
https://secwatch.observer/filing/0001031203-24-000040.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/gpi-20240515.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

15fc65001c87f20af2cdcd62026812e48adc504c

GROUP 1 AUTOMOTIVE INC shareholders approved Advisory vote on compensation of Named Executive Officers at the 2024-05-15 meeting.

Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

720aea13f632c84d47cb4c3cf6f5f7a4df36b2b8

GROUP 1 AUTOMOTIVE INC shareholders approved Approval of 2024 Plan including authorization of 700,000 shares and term extension at the 2024-05-15 meeting.

Proposal 5: The 2024 Plan was approved, including the authorization of 700,000 shares to be used for awards and the extension of the term thereof to May 15, 2034, based on the following votes:

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

97be6c4a19583c518cd65fccbae29095d74058b3

GROUP 1 AUTOMOTIVE INC shareholders approved Approval of 2024 ESPP including share increase and term extension at the 2024-05-15 meeting.

Proposal 4: The 2024 ESPP was approved, including the increase to the number of shares available for issuance under the 2024 ESPP and extension of the term thereof to May 24, 2034, based on the following votes:

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

c7edb91d744e35a038c3ef98c44cdeabe2d96efa

GROUP 1 AUTOMOTIVE INC shareholders approved Election of nine director nominees at the 2024-05-15 meeting.

Proposal 1: The nine director nominees named in the Proxy Statement were elected as directors to serve until the 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified, based upon the following votes:

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

ebb3ead15f00cabcd355cd226f5ce46547537cdf

GROUP 1 AUTOMOTIVE INC shareholders approved Ratification of Deloitte & Touche LLP as independent auditor at the 2024-05-15 meeting.

Proposal 3: The ratification of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, was approved, based upon the following votes:

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

Comparable filings

HBIO

Stockholders approve 400,000-share increase in 2021 Incentive Plan and amendment to ESPP

HARVARD BIOSCIENCE INC June 2, 2026, 4:01 PM ET other Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

This filing

Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:

Comparable filing

Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538

Filing page SEC filing

EDSA

Edesa Biotech shareholders approve equity plan amendment adding 750K shares

Edesa Biotech, Inc. May 29, 2026, 4:15 PM ET other Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

This filing

Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:

Comparable filing

Proposal No. 3 - Approval of Amendment to the 2019 Equity Incentive Compensation Plan The shareholders approved an amendment to the Company’s 2019 Plan to (i) increase the number of shares available for issuance thereunder plan by 750,000 shares and (ii) eliminate the annual per participant option grant limit. For Against Abstain Broker Non-Votes 2,613,551 130,589 10,680 2,147,101

Filing page SEC filing

KYTX

Kyverna Therapeutics shareholders elect Ian Clark and Christi Shaw as Class II directors, ratify BDO USA auditor

Kyverna Therapeutics, Inc. June 2, 2026, 4:30 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:

Comparable filing

Director Nominee Votes For Votes Withheld Broker Non-Votes Ian Clark 31,505,902 3,255,231 9,225,874 Christi Shaw 34,528,865 232,268 9,225,874

Filing page SEC filing

PARK

Park Dental Partners announces shareholder voting results at 2026 annual meeting

Park Dental Partners, Inc. June 2, 2026, 4:05 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:

Comparable filing

The Company’s shareholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Filing page SEC filing

ADCT

ADC Therapeutics shareholders approve capital range increase, equity plan expansion at 2026 AGM

ADC Therapeutics SA June 2, 2026, 4:01 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:

Comparable filing

Proposal #12 : Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company’s capital range (article 4a), conditional share capital for employee participation (article 4b) and conditional share capital for financing, acquisitions and other purposes (article 4c) as well as the introduction of article 4d regarding a conditional share capital based on the capital range The shareholders approved (i) amendments to article 4a paragraph 1 of the articles of association to increase the Company’s capital range from CHF 8,375,974.48 (lower limit) to CHF 12,354,128.80 (upper limit) to CHF 10,378,109.12 (lower limit) to CHF 15,567,163.68 (upper limit) (Proposal #12a), (ii) amendments to article 4b paragraph 1 of the articles of association to increase the Company’s conditional share capital for employee participation from 9,887,629 common shares (CHF 791,010.32) to 16,836,253 common shares (CHF 1,346,900.24) (Proposal #12b)

Filing page SEC filing

SGA

Saga Communications shareholders elect all 7 directors, approve say-on-pay and auditor ratification

SAGA COMMUNICATIONS INC June 2, 2026, 4:00 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:

Comparable filing

The seven nominees for election as directors for the ensuing year, and until their successors are elected and qualified, were elected and received the following votes:

Filing page SEC filing

XBP

XBP Global Holdings annual meeting elects directors, approves auditor and say-on-pay

XBP Global Holdings, Inc. June 1, 2026, 5:00 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:

Comparable filing

Proposal 4 — To consider and vote upon a proposal to approve, on an advisory (non-binding) basis, the frequency of future say-on-pay votes: Votes For 1 Year Votes For 2 Years Votes For 3 Years Votes Abstained Broker Non-Votes 9,200,507 333 488 332,030 577,920

Filing page SEC filing

AXON

Axon shareholders elect all 9 director nominees and approve say-on-pay at 2026 annual meeting

AXON ENTERPRISE, INC. June 1, 2026, 4:10 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:

Comparable filing

Proposal No. 2 — Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers ( “ Say-on-Pay ” ) The non-binding advisory vote to approve the compensation of the Company’s named executive officers was approved as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES 54,903,698 6,239,017 112,972 11,665,236

Filing page SEC filing

Source: SEC EDGAR
accession 0001031203-24-000040
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.